BlackRock expands its dominant position in the U.S., overseas to Europe.
BlackRock's iShares Bitcoin Trust ETF (IBIT) is the fastest growing fund of its kind, and, with assets under management (AuM) currently totalling some $47.3bn as of April 3rd, the largest.
Now though, in a ‘cat-amongst-the-pigeons’ move, the number one BTC fund issuer has entered the smaller, though highly competitive, European crypto exchange traded product (ETP) market, where the first Bitcoin ETP was launched as far back as December 2019.
As Bloomberg notes, “While ETPs linked to cryptocurrencies have traded on European bourses for years, the market’s $13.6 billion size pales in comparison to that of the US.”
The iShares Bitcoin ETP listed on Euronext Amsterdam (ticker: BTCN), Euronext Paris (IB1T), and Frankfurt-based Deutsche Boerse’s Xetra (IB1T) on March 25th.
IB1T marks BlackRock’s first Bitcoin product of any kind outside of North America. Just like IBIT, IB1T utilizes a regulated CF Benchmarks index for NAV calculation, in this case CME CF Bitcoin Reference Rate (BRR).
BRR is our first BTC price variant, and has been integrated into the settlement procedure for CME Group’s, Bitcoin futures and options – among the first ever regulated crypto products products – for almost a decade; making BRR truly the most utilized and liquid institutional Bitcoin price.
Meanwhile IBIT, listed on Nasdaq, tracks our CME CF Bitcoin Reference Rate - New York Variant (BRRNY).
A new iShares BTC ETP tracking BRRNY's European-hours variant, could enjoy market structural liquidity effects, ultimately benefitting investors and consumers.
Again, like IBIT, Coinbase’s custody services secures IB1T's physical Bitcoin holdings, while Bank of New York Mellon is fund Administrator.
iShares has a 10 basis point fee reduction in place till end-2025, on a Total Expense Ratio that was already among the lowest relative to European Bitcoin funds, at 0.25%.
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
CF Benchmarks
CF Benchmarks